{"originalText": "，患者2014-12月因升结肠癌于2014-12-05我院行“腹腔镜左半结肠切除术”，，术后病理：结肠中分化腺癌，癌组织浸润肠壁浆膜上层，未见淋巴结转移。术后未行辅助治疗，规律随诊。2015-03-16查CEA 170.9NG/ML，CA199 193.4U/ML，遂行PET/CT检查，示右附件区体积增大，局部代谢活跃，疑恶性病变，肠癌转移与原发瘤相鉴别；甲状腺右叶低密度影代谢活跃，考虑甲状腺癌可能性大；右股骨颈及股骨下段骨质破坏，代谢较活跃，疑骨良性病变，不除外甲状腺癌转移可能，建议随诊。2015-04-09全麻上行“甲状腺右叶+峡部切除+右VI区淋巴结清扫术+右侧喉返神经探查术+全子宫两附件切除术”，，术后病理：结肠癌卵巢转移；结节性甲状腺肿。术后于2015-5-7、05-28行XELOX方案化疗2程，化疗后出现II度恶心、I度腹泻，未规律监测血象，复查2次血常规未见骨髓抑制。现遵主诊教授意见未行上一程化疗入院。近期以来，患者精神、睡眠可，食欲一般，大便2-3次/天，成形便，小便基本正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 16}, {"end_pos": 41, "label_type": "手术", "overlap": 0, "start_pos": 31}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 49, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 63}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 102, "end_pos": 105}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 117, "end_pos": 122}, {"label_type": "影像检查", "overlap": 0, "start_pos": 135, "end_pos": 141}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 167, "end_pos": 171}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 195, "end_pos": 199}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 234, "end_pos": 240}, {"label_type": "手术", "overlap": 0, "start_pos": 263, "end_pos": 304}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 312, "end_pos": 327}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}]}
